Aprecia offers commercial-scale production systems designed to accelerate clinical development and optimize commercial success. Our industry-leading 3DP formulation and manufacturing platforms transform drug development and delivery, meeting the unprecedented demand for complex and patient-friendly dosage forms.



Aprecia joined with MIT Technology to build groundbreaking 3DP pharmaceutical technology with a mission towards advancing personalized medicine.



With the first-of-its-kind innovations, Aprecia enables NDAs, extends product lifestyles, and accelerates clinical development.

· Powder-based 3DP techniques use the widest set of ready materials compared to

other additive manufacturing techniques.

· The Binder Jetting technique provides the most flexibility when creating

pharmaceutical formulations.

· Aprecia is the first and only company in the world to obtain regulatory approval

for a 3DP pharmaceutical product and utilized the MIT invented Binder Jetting

technique to realize that feat. This transformed the use of 3DP from rapid

prototyping in a laboratory setting to at scale production in a cGMP environment.



Aprecia is a sister company of PRASCO The Leader In Authorized Generics and Trusted Pharmaceutical Partner



Aprecia is poised to revolutionize pharmaceutical manufacturing through precision medicine and distributed manufacturing.